Assessment of the scientific-technological production in molecular biology in Brazil (1996-2007): the contribution of genomics programs

Autor(es)

Meneghini, Rogerio ^{[1, 2, 3]} ; Gamba, Estevao C. ^[2]

Afiliação do(s) autor(es)

^[1] Univ Fed Sao Paulo UNIFESP, SciELO Fundacao Apoio, BR-04037003 Sao Paulo - Brazil

^[2] Univ Fed Sao Paulo UNIFESP, Dept Med Informat, BR-04023901 Sao Paulo - Brazil

^[3] Univ Fed Sao Paulo FapUNIFESP, Fundacao Apoio, BR-04037003 Sao Paulo - Brazil

• Tipo de documento: Artigo Científico
• Fonte: Anais da Academia Brasileira de Ciências; v. 83, n. 2, p. 745-760, JUN 2011.
• Citações Web of Science: 0

Resumo

Several genome sequencing programs were launched in Brazil by the end of the nineties and the early 2000s.The most important initiatives were supported by the ONSA program (http://watson.fapesp.br/onsa/Genoma3.htm) and aimed at gaining domain in genomic technology and bringing molecular biology to the state of art. Two mainsets of data were collected in the 1996-2007 period to evaluate the results of these genome programs: the scientific production (Scopus and Web of Science databases) and the register of patents (US Patent and Trademark Office), both related to the progress of molecular biology along this period. In regard to the former, Brazil took a great leap in comparison to 17 other developed and developing countries, being only surpassed by China. As to the register of patents in the area of molecular biology, Brazil's performance lags far behind most of the countries focused in the presentstudy, confirming the Brazilian long-standing tendency of poor achievements in technological innovations when compared with scientific production. Possible solutions to surpass this inequality are discussed. (AU)

• Processo FAPESP: 06/56462-9 - Projeto para avaliação do impacto de programas brasileiros de ciência e tecnologia
• Beneficiário: Rogerio Meneghini
• Modalidade de apoio: Auxílio à Pesquisa - Regular